SLGL - ソル・ゲル・テクノロジ―ズ (Sol-Gel Technologies Ltd.)

SLGLのニュース

   VBL Therapeutics's Cancer Trial, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:VBLT)  2020/09/15 15:40:14 Seeking Alpha
VBL Therapeutics reports progress for metastatic colorectal cancer trial. Sol-Gel Technologies reports FDA acceptance of Rosacea NDA.
   Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Epsolay® for the Treatment of Inflammatory Lesions of Rosacea  2020/09/10 20:01:00 GlobeNewswire
- PDUFA Goal Date Set for April 26, 2021 - Potential to be first FDA-approved single-agent benzoyl peroxide prescription drug product NESS ZIONA, Israel,…
   Sol-Gel Technologies Gets Makeover, Stock More Than Doubled In A Month  2020/01/02 03:09:00 RTT News
Shares of Sol-Gel Technologies Ltd. (SLGL) have more than doubled over the last one month, thanks to positive data from its acne trials..
   Sol Gel Technologies News: SLGL Stock Skyrockets 80% on Acne Drug Study  2019/12/30 19:53:24 InvestorPlace
Sol Gel Technologies (SLGL) news for Monday concerning an acne drug study with incredibly positive results has SLGL stock taking off.
   Why Sol-Gel Shares Are Ripping Higher  2019/12/30 14:57:55 Benzinga
Shares of the Israel-based, clinical-stage dermatology company Sol Gel Technologies Ltd (NASDAQ: SLGL ) were more than doubling Monday. Sol-Gel's Acne Treatment Found Effective The top-line results from two pivotal Phase 3 trials for Twyneo showed statistically significant improvement on all co-primary endpoints in the treatment of patients with acne vulgaris, Sol-Gel said. Twyneo is a combination of microencapsulated tretinoin 0.1% and microencapsulated benzoyl peroxide 3% cream. "We are excited to share these robust results which further demonstrate the potential of our microencapsulation technology to deliver first-of-its kind efficacy in a topical acne treatment," Dr. Alon Seri-Levy, … Full story available on Benzinga.com
   Sol-Gel Technologies Gets Makeover, Stock More Than Doubled In A Month  2020/01/02 03:09:00 RTT News
Shares of Sol-Gel Technologies Ltd. (SLGL) have more than doubled over the last one month, thanks to positive data from its acne trials..
   Sol Gel Technologies News: SLGL Stock Skyrockets 80% on Acne Drug Study  2019/12/30 19:53:24 InvestorPlace
Sol Gel Technologies (SLGL) news for Monday concerning an acne drug study with incredibly positive results has SLGL stock taking off.
   Why Sol-Gel Shares Are Ripping Higher  2019/12/30 14:57:55 Benzinga
Shares of the Israel-based, clinical-stage dermatology company Sol Gel Technologies Ltd (NASDAQ: SLGL ) were more than doubling Monday. Sol-Gel's Acne Treatment Found Effective The top-line results from two pivotal Phase 3 trials for Twyneo showed statistically significant improvement on all co-primary endpoints in the treatment of patients with acne vulgaris, Sol-Gel said. Twyneo is a combination of microencapsulated tretinoin 0.1% and microencapsulated benzoyl peroxide 3% cream. "We are excited to share these robust results which further demonstrate the potential of our microencapsulation technology to deliver first-of-its kind efficacy in a topical acne treatment," Dr. Alon Seri-Levy, … Full story available on Benzinga.com
   Sol Gel Technologies (NASDAQ:SLGL) Posts Quarterly Earnings Results  2019/11/16 18:45:56 Modern Readers
Sol Gel Technologies (NASDAQ:SLGL) posted its earnings results on Wednesday. The company reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.12), Fidelity Earnings reports. The company had revenue of $4.73 million for the quarter, compared to analysts’ expectations of $6.56 million. Sol Gel Technologies had a negative […]
   Sol-Gel Technologies Ltd. (SLGL) May Report Negative Earnings: Know the Trend Ahead of Q2 Release  2019/08/07 14:30:27 Zacks Investment Research
Sol-Gel Technologies Ltd. (SLGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Sol-Gel Technologies Gets Makeover, Stock More Than Doubled In A Month  2020/01/02 03:09:00 RTT News
Shares of Sol-Gel Technologies Ltd. (SLGL) have more than doubled over the last one month, thanks to positive data from its acne trials..
   Sol Gel Technologies News: SLGL Stock Skyrockets 80% on Acne Drug Study  2019/12/30 19:53:24 InvestorPlace
Sol Gel Technologies (SLGL) news for Monday concerning an acne drug study with incredibly positive results has SLGL stock taking off.
   Why Sol-Gel Shares Are Ripping Higher  2019/12/30 14:57:55 Benzinga
Shares of the Israel-based, clinical-stage dermatology company Sol Gel Technologies Ltd (NASDAQ: SLGL ) were more than doubling Monday. Sol-Gel's Acne Treatment Found Effective The top-line results from two pivotal Phase 3 trials for Twyneo showed statistically significant improvement on all co-primary endpoints in the treatment of patients with acne vulgaris, Sol-Gel said. Twyneo is a combination of microencapsulated tretinoin 0.1% and microencapsulated benzoyl peroxide 3% cream. "We are excited to share these robust results which further demonstrate the potential of our microencapsulation technology to deliver first-of-its kind efficacy in a topical acne treatment," Dr. Alon Seri-Levy, … Full story available on Benzinga.com
   Sol Gel Technologies (NASDAQ:SLGL) Posts Quarterly Earnings Results  2019/11/16 18:45:56 Modern Readers
Sol Gel Technologies (NASDAQ:SLGL) posted its earnings results on Wednesday. The company reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.12), Fidelity Earnings reports. The company had revenue of $4.73 million for the quarter, compared to analysts’ expectations of $6.56 million. Sol Gel Technologies had a negative […]
   Sol-Gel Technologies Ltd. (SLGL) May Report Negative Earnings: Know the Trend Ahead of Q2 Release  2019/08/07 14:30:27 Zacks Investment Research
Sol-Gel Technologies Ltd. (SLGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

calendar